Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction
Toronto, Ontario–(Newsfile Corp. – December 5, 2025) – Apolo V Acquisition Corp. (TSXV: AFV.P) (“Apolo“) and TelyRx, Inc. (“TelyRx“), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce that they have entered into a non-binding letter of intent dated December 5, 2025, which outlines the principle terms and conditions pursuant […]